Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0021218067
Mon, 27.09.2021
Evolva Holding SA
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRReinach, September 27, 2021 - Evolva (SIX:EVE), informs that it has issued 40'000'000 new shares out of authorized capital to cover present and future share delivery obligations under the convertible loan agreement with Nice & Green SA, dated June 26, 2020, as amended.
The listing and f [ … ]
Thu, 26.08.2021
Evolva Holding SA
Reinach, August 26, 2021 - Evolva (SIX:EVE), the Swiss biotech company focused on the research, development and commercialization of ingredients based on nature, announced today the results for the first half of the year and provided corporate highlights.
Highlights
First half 2021 total revenue grew 60% compared to previous year reachin [ … ]
Mon, 17.05.2021
Evolva Holding SA
Reinach, May 17, 2021 - Evolva (SIX:EVE), the Swiss biotech company focused on the research, development and commercialization of products based on nature, today signed an agreement with Nice & Green, a Swiss investment firm, to secure additional funding.
The major activities to be funded include the expansion and diversification of manufactur [ … ]
Wed, 21.04.2021
Evolva Holding SA
Reinach, April 21, 2021 - Evolva (SIX:EVE) today issues a trading update in respect to the period from January to March 2021.
Sales continued to progress well, with the trends and momentum described in our FY 2020 results on 25 February 2021. We are seeing a particularly strong performance in Health Ingredients driven by consumer trends, and weake [ … ]
Thu, 08.04.2021
Evolva Holding SA
Reinach, April 8, 2021 - Evolva shareholders approved all proposals put forward by the Board of Directors at Evolva's Annual General Meeting (AGM). In accordance with the Swiss COVID-19 Ordinance 3, the 2021 AGM was held without shareholders being physically present. Accordingly, shareholders exercised their shareholder rights via the Independent P [ … ]
Wed, 20.01.2021
Evolva Holding SA
Reinach, January 20, 2021 - Evolva (SIX:EVE), the Swiss biotech company focused on the research, development and commercialization of products based on nature, launched L-arabinose (previously known as EVE-X157/Z4), a natural sugar blocker used in food and beverages and reducing sugar applied in food processing.«As people around the world continue [ … ]